How to Get GLP-1 Patients as a Psychiatrist in Illinois

You’ve seen it in your practice: patients gaining 30, 40, 50 pounds on antipsychotics. Patients asking if there’s ‘anything you can do’ about their weight. Maybe you’ve even had a few ask about Ozempic directly.

Here’s the opportunity: demand for GLP-1 weight-loss treatment has exploded. By 2025, an estimated 6% of Americans — roughly 20 million people — were actively taking GLP-1 medications. That’s a 600% increase in weight-loss usage over six years. And most of these patients can’t find providers to prescribe them.

As a psychiatrist, you’re uniquely positioned to fill this gap. You already manage complex medication regimens. You understand behavior change. You have ongoing relationships with patients who desperately need weight-loss solutions. And unlike primary care docs drowning in 15-minute appointments, you have the clinical depth to address the psychological side of obesity — the depression, the binge eating, the medication-induced weight gain that traditional weight-loss clinics ignore.

The question isn’t whether you should add GLP-1 services. It’s whether you can do it without burning yourself out while capturing a lucrative, high-demand revenue stream.

Let’s talk about how.

Why Psychiatrists Are Already Prescribing GLP-1s (And Why You Should Too)

Your Patients Are Already Asking

A late-2023 survey across major psychiatric departments found nearly half of psychiatrists were already prescribing or recommending Ozempic or similar weight-loss drugs. This isn’t a side specialty anymore — it’s becoming standard psychiatric care.

Why? Because psychiatric medications cause weight gain. Antipsychotics, mood stabilizers, certain antidepressants — they all pack on pounds. Your patients gain weight, their self-esteem tanks, their diabetes worsens, and they start skipping their psych meds because they’d rather be unstable than fat.

GLP-1s solve this. They help patients lose the medication-induced weight while staying on the psychiatric treatments they need. Some early research even suggests GLP-1s might independently improve certain psychiatric symptoms — though more data is needed, the metabolic-mental health connection is real.

The Market Gap Is Massive

Here’s the reality: most patients seeking GLP-1s can’t get them. There aren’t enough obesity medicine specialists to meet demand. Primary care doctors are overwhelmed and often uncomfortable prescribing weight-loss medications. Endocrinologists are booked months out.

The relatively small number of doctors trained in obesity medicine cannot handle the tens of thousands of new patients starting GLP-1 treatments each week. This shortage creates opportunity — especially for telehealth providers who can reach patients across entire states.

And unlike bariatric surgery or intensive lifestyle programs, GLP-1 therapy is straightforward to deliver via telehealth. No need for in-person exams (these aren’t controlled substances). No special equipment. Just video consults, lab monitoring, and dose titration — all within a psychiatrist’s wheelhouse.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

The Economics of GLP-1 Prescribing: Cash-Pay vs Insurance

Before you scale, understand the business model. GLP-1 practices typically run one of two ways: cash-pay or insurance-based. Each has trade-offs.

Cash-Pay: The Dominant Model

Most telehealth weight-loss practices operate on cash-pay for a simple reason: insurance coverage for obesity drugs is terrible.

As of mid-2024, only 13 state Medicaid programs covered GLP-1s for weight loss (including California, Pennsylvania, and Illinois). Most private insurers exclude obesity medications entirely, covering GLP-1s only for diabetes. This leaves patients paying out-of-pocket for both the medication ($1,300+/month for brand-name Wegovy, a few hundred for compounded semaglutide) and the provider visits.

Cash-pay advantages:

• No prior authorizations, no insurance denials
• Direct revenue — patients pay for consults upfront
• Faster to set up (no credentialing delays)
• Pairs naturally with patients already paying cash for meds

Typical cash-pay structure:

• Initial consult: $150–$300 (comprehensive evaluation, labs review, treatment planning)
• Follow-ups: $75–$150 (monthly for first 3–6 months, then quarterly)
• Or subscription models: $99–$199/month including consults, coaching, sometimes compounded medication

The downside? You limit access to patients who can afford cash. But the reality is, many GLP-1 patients are already paying cash for their medications. Adding a $100 monthly consult fee is marginal compared to the drug cost.

Insurance: Wider Access, More Admin

Accepting insurance expands your patient pool to those who can only afford treatment if visits are covered. You can bill standard E/M codes for obesity counseling or Medicare’s G0447 code for obesity behavioral counseling (if you qualify).

Insurance advantages:

• Access to patients who need insurance coverage
• Some states’ Medicaid programs now cover GLP-1s for obesity (CA, PA, IL among them)
• Medicare is piloting coverage for weight-loss drugs starting in 2026 — if this expands, insurance models become more viable

Insurance disadvantages:

• Extensive documentation requirements
• Prior authorizations for medications (time-consuming, often denied)
• Lower reimbursement for consults
• Insurance may deny coverage for obesity drugs even if they cover the visits

Hybrid approach: Many psychiatrists charge cash for the initial comprehensive evaluation (which insurance underpays anyway), then bill insurance for follow-up visits if the patient has good coverage. This balances revenue with access.

Bottom line: be transparent with patients about what’s covered and what’s not. Help them estimate total monthly costs (meds + visits) before they commit.

How to Get GLP-1 Patients: Internal Referrals + Smart Marketing

Growing a GLP-1 practice doesn’t require gambling thousands on marketing campaigns with uncertain ROI. Start smart, then scale.

Start With Your Existing Patients (Zero Marketing Cost)

Your current psychiatric patients are your best first source. Identify patients who:

• Have gained significant weight on psychiatric medications
• Have BMI ≥30 (or ≥27 with comorbidities like diabetes, hypertension)
• Express frustration about weight gain
• Have binge eating disorder or emotional overeating

Bring it up during medication reviews: ‘I know the medication has been helping your mood, but I see you’ve gained weight. We now offer medical weight management with GLP-1s that can help reverse that. Would you like to discuss it?’

This ‘internal conversion’ approach:

• Builds on existing trust
• Requires zero marketing spend
• Addresses patients’ real pain points
• Differentiates your practice (comprehensive care, not just symptom management)

External Marketing: Platform-Based Patient Acquisition

Once you’ve built your workflow with existing patients, scale externally. The smartest way? Join a telehealth platform that handles patient acquisition for you.

Why platforms make economic sense:

DIY marketing (SEO, Google Ads, directory listings) sounds appealing until you factor in the real costs:

• Google Ads for mental health keywords: $15–$40+ per click, with most clicks not converting to booked patients. Realistic cost per booked patient: $200–$400+
• SEO: Takes 6–12 months of consistent investment before generating meaningful patient flow. Most solo providers don’t have the expertise or patience
• Psychology Today, Zocdoc: Monthly subscription fees + you compete with hundreds of other providers on the same page. Zocdoc charges $35–$100+ per booking, plus subscription
• Total monthly marketing spend: $3,000–$5,000+ with uncertain results and months of testing before ROI

Platform model (like Klarity Health):

• Pay-per-appointment model — you only pay a standard listing fee when a qualified patient books with you
• No upfront marketing spend or monthly subscriptions
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule and capacity

The math: Instead of spending $4,000/month on marketing that might yield 10 new patients, you pay only when patients actually book. That’s guaranteed ROI vs. gambling on marketing channels.

For providers starting out or scaling, this removes the risk entirely. Let the platform handle patient acquisition (they’re already investing in ads, SEO, and patient education), and you focus on delivering care.

Other Marketing Channels

If you go independent:

• SEO: Create content about GLP-1s + mental health (‘Managing Weight Gain from Psychiatric Medications,’ ‘Psychiatrist-Led Weight Loss Programs’)
• Social media: Share patient success stories (with permission), education about obesity’s impact on mental health
• Referral relationships: Let local PCPs, therapists, and dietitians know you offer GLP-1 services. Many will gladly refer patients they can’t help

Positioning tip: Emphasize your psychiatric expertise as a differentiator. Generic weight-loss clinics can’t address binge eating, medication interactions, or depression. You can. That’s your competitive advantage.

Telehealth Compliance: What You Need to Know

GLP-1 agonists are not controlled substances, which means you can prescribe them via telehealth without the Ryan Haight Act’s in-person exam requirement. This opens up entire states for remote practice.

Licensure Requirements

Rule #1: You must be licensed in the patient’s state. No exceptions.

For psychiatrists (MD/DO):

• Full prescriptive authority in all states for GLP-1s
• Some states offer expedited licensing through the Interstate Medical Licensure Compact (IMLC) — Texas, Florida, Pennsylvania, and Illinois are members; California and New York are not
• Florida bonus: Out-of-state physicians can register for Florida Telehealth Provider status without full licensure (allows telemedicine to FL patients, including GLP-1 prescribing)

For PMHNPs/PAs:

• Scope varies by state — most require physician collaboration agreements
• California: NPs must work under physician supervision unless they achieve independent ‘104 NP’ status (earliest certifications in Jan 2026 after 3-year supervised requirement)
• Texas: Strict collaboration required — NPs need Prescriptive Authority Agreement with a Texas physician
• Florida: PMHNPs need physician oversight (NP autonomous practice limited to primary care only)
• New York: Experienced NPs (≥3,600 hours practice) can prescribe independently
• Pennsylvania: All NPs require Collaborative Agreement with physician
• Illinois: NPs can achieve Full Practice Authority after 4,000 hours + 250 hours additional education

If you’re an NP in a restricted state, partner with a supervising physician or join a platform that handles the collaboration structure.

Standard of Care via Telehealth

Each state requires you meet the same standard of care as in-person treatment:

Initial evaluation must include:

• Comprehensive weight and medical history
• BMI calculation and weight goals
• Review of contraindications (history of medullary thyroid carcinoma, pancreatitis, pregnancy)
• Baseline labs (A1c, fasting glucose, liver enzymes, possibly TSH)
• Mental health screening (critical given your psychiatric expertise)
• Informed consent about off-label use (if prescribing Ozempic vs. FDA-approved Wegovy)

State-specific requirements:

• California: Obtain verbal or written patient consent for telehealth and document it
• Texas: Can establish patient relationship via synchronous audio-visual consult (no in-person visit required)
• Florida: No in-person exam mandate; video evaluation sufficient if adequate for diagnosis and treatment

Follow-up monitoring:

• At least monthly during dose titration (first 3–6 months)
• Address common side effects (nausea, GI issues)
• Monitor weight loss progress and adjust dosing
• Ongoing mental health check-ins (watch for mood changes, though FDA found no clear suicide risk)

Medication Sourcing: FDA-Approved vs. Compounded

FDA-approved GLP-1s for obesity:

• Wegovy (semaglutide)
• Saxenda (liraglutide)
• Zepbound (tirzepatide)

These are expensive ($1,300+/month without insurance) but carry full regulatory approval.

Compounded semaglutide:

• Much cheaper ($200–$400/month)
• Legal when there’s a drug shortage (which has been ongoing)
• Compliance risk: Use only licensed, FDA-registered compounding pharmacies. The FDA has warned about unregulated compounders

Your responsibility: Ensure any pharmacy you partner with is properly licensed and uses FDA-compliant ingredients. If in doubt, stick to FDA-approved medications to avoid legal liability.

Scaling Without Burning Out: Workflow + Team-Based Care

Here’s the trap: GLP-1 demand is so high, you could easily book yourself into 40 weight-loss consults per week on top of your psychiatric caseload. That’s a path to burnout.

How to scale sustainably:

1. Standardize Your Intake Process

Use digital intake forms to gather comprehensive history before the first appointment:

• Weight history and previous weight-loss attempts
• Medical conditions and current medications
• Mental health status (depression, binge eating, body image issues)
• Diet and exercise patterns

This saves 15–20 minutes per initial consult and ensures you don’t miss critical contraindications.

Create standardized order sets:

• ‘Obesity Intake Panel’ labs (A1c, TSH, liver panel) with one click
• GLP-1 titration protocols (standardized dose schedules)
• Template documentation for common scenarios

2. Delegate Non-Specialist Tasks

You don’t need to do everything yourself.

Medical assistants or RNs can:

• Gather interim data (weights, blood pressure, symptom questionnaires)
• Handle routine patient questions via portal messaging
• Schedule follow-ups and send appointment reminders
• Review lab results for abnormalities before your review

Health coaches or dietitians can:

• Lead weekly group support sessions (virtual)
• Provide dietary counseling and exercise planning
• Conduct check-ins at 2-week intervals between your appointments
• Communicate any issues back to you for medication decisions

Team-based care example:

• Month 1: You see patient for initial eval + prescribe
• Month 2: Health coach check-in via video (weight review, diet coaching)
• Month 3: You see patient for dose adjustment
• Month 4: RN phone check-in (collect weight, BP, side effects)
• Month 5: You see patient for maintenance planning

This lets you manage 3x the patient volume without 3x the appointment hours.

3. Leverage Group Visits

Monthly group support sessions (30–45 minutes via Zoom):

• Led by you, an NP, or a health coach
• Cover common topics: managing nausea, plateau troubleshooting, nutrition tips
• Patients ask questions, share successes
• One session can serve 10–15 patients simultaneously

This reduces repetitive one-on-one counseling while improving patient engagement and retention.

4. Use Technology for Efficiency

Telehealth platform features to leverage:

• Automated appointment reminders (reduce no-shows)
• Online scheduling (eliminate phone tag)
• Asynchronous messaging for simple questions (‘Is nausea normal on this dose?’)
• Remote patient monitoring (connected scales that auto-report weights)

AI-driven automation:

• Chatbots for FAQs
• Automated educational content sent when prescriptions are filled
• Weight trend graphs that flag patients who need early intervention

Result: 15-minute follow-ups become 10-minute focused check-ins. You can see 6 patients per hour instead of 4, without rushing.

5. Set Boundaries to Prevent Burnout

Schedule management:

• Dedicate specific half-days to GLP-1 consults (don’t scatter them throughout the week)
• Cap daily consults (e.g., max 12 weight-loss visits per day)
• Build in 5-minute buffer blocks between appointments for notes

Communication boundaries:

• Set firm availability hours for patient messages (e.g., 9 AM–5 PM weekdays)
• Use delayed email replies or an answering service after hours
• Train patients: ‘Routine questions are answered within 24 business hours; emergencies call this number’

Gradual scaling:

• Start with 5–10 GLP-1 patients
• Refine your workflow for 2–3 months
• Add 10 more patients
• Repeat until you hit capacity — then add a team member before adding more patients

6. Monitor Your Own Well-Being

Watch for burnout signs:

• Emotional exhaustion
• Depersonalization (cynicism about patients)
• Declining work performance or satisfaction

If you hit these:

• Temporarily cap new patient intakes
• Hire a part-time PMHNP to share the load
• Adjust your schedule (cut back 1 day per week, add a long weekend monthly)

Remember: A sustainable practice serves patients better long-term than a burned-out provider trying to do everything alone.

State-by-State Regulatory Summary

Key takeaway: If you’re an NP in Texas, Florida, or Pennsylvania, you’ll need a supervising physician arrangement. If you’re in New York (with experience) or Illinois (with FPA certification), you can practice independently. California is transitioning to independence starting 2026.

FAQ: GLP-1 Prescribing for Psychiatrists

Q: Do I need special certification to prescribe GLP-1s?

No. As a licensed psychiatrist, you have full prescriptive authority for GLP-1 medications. Obesity medicine board certification is optional — it adds credibility but isn’t required. Many psychiatrists successfully prescribe GLP-1s with just CME training in obesity pharmacotherapy.

Q: Can I prescribe GLP-1s via telehealth without seeing patients in person?

Yes. GLP-1 agonists are not controlled substances, so the Ryan Haight Act doesn’t apply. You can establish the patient relationship and prescribe entirely via video in every state, as long as you meet that state’s standard of care for telehealth.

Q: What if a patient has psychiatric side effects from GLP-1s?

Monitor closely. Early reports suggested possible mood changes or suicidal ideation, but by 2026 the FDA found no clear causal link and directed removal of suicide warnings. Still, as a psychiatrist, you’re uniquely qualified to screen for and manage any mood effects. Document baseline mental health status and ask about mood changes at every follow-up.

Q: How do I handle patients who plateau or don’t lose weight?

Address lifestyle factors (diet, exercise, sleep), check medication adherence, consider dose adjustments, and screen for underlying issues (hypothyroidism, binge eating). Some patients need adjunct behavioral therapy or dietitian support. This is where your psychiatric expertise shines — you can address the psychological barriers to weight loss that other providers miss.

Q: Can I prescribe compounded semaglutide legally?

Yes, when there’s an FDA-declared drug shortage (which has been ongoing). Use only licensed, FDA-registered 503B compounding pharmacies. Document the shortage and patient need in your chart. Avoid sketchy online compounders — stick to reputable partners.

Q: What’s my malpractice exposure?

Standard for any prescribing. Ensure your malpractice policy covers weight-management services (inform your insurer). Follow standard of care: appropriate patient selection, informed consent, baseline labs, regular monitoring, documentation. If you’re thorough and conservative with patient selection, risk is minimal.

Ready to Add GLP-1 Services to Your Practice?

The opportunity is real. Millions of patients need GLP-1 treatment. Most can’t find qualified providers. You have the clinical skills, the patient relationships, and the psychiatric expertise to deliver comprehensive weight-loss care that addresses both body and mind.

You can start small — convert a few existing patients, refine your workflow, scale gradually with team support and smart technology. Or you can accelerate growth by joining a platform that handles patient acquisition, letting you focus on what you do best: treating patients.

The choice is yours: spend months and thousands building your own marketing funnel, or start seeing pre-qualified GLP-1 patients next week through a platform like Klarity Health.

Either way, the demand isn’t going away. The question is whether you’ll capture it — sustainably, profitably, and without burning out.

Ready to explore platform-based patient acquisition? Joining Klarity Health gives you immediate access to patients seeking GLP-1 treatment, built-in telehealth infrastructure, and a pay-per-appointment model that eliminates upfront marketing risk. You focus on patient care; we handle the rest.

References

1. Axios – ‘Just how many Americans are taking GLP-1s now’ (Fair Health data on usage), May 27, 2025. https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing

2. ConfectioneryNews – ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry,’ October 20, 2025. https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/

3. Time – ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny,’ August 22, 2025. https://time.com/7311517/cost-weight-loss-drugs-skinny/

4. Axios – ‘America’s doctors need more obesity medicine training,’ May 28, 2024. https://www.axios.com/2024/05/28/us-doctors-obesity-health-care-training

5. Axios – ‘States slow to cover GLP-1s for weight loss,’ November 5, 2024. https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss

Source:

• https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing#:~:text=More%20than%202,their%20original%20approved%20use
• https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/#:~:text=GLP,real%20number%20according%20to%20Kim
• https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318#:~:text=Drugs%20pharmanewsintel
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=equivalent%20to%20in,FDA%2C%20pharmacy%2C%20and%20board%20alerts
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,with%20chart%20review%2C%20plus%20meetings
• https://www.singleaimhealth.com/news/nurse-practitioner-collaborative-agreement-templates-50-state-guide#:~:text=In%20Pennsylvania%2C%20Certified%20Registered%20Nurse,the%20CRNP%20and%20the%20collaborating
• https://www.wheel.com/state-telehealth-regulations/florida#:~:text=Are%20There%20Online%20Prescription%20Restrictions,for%20Telehealth%20in%20Florida
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=most%20insurances%20cover%20the%20medication,A%20recent%20Annals%20of%20Internal
• https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss#:~:text=What%20they%20found%3A%20In%20all%2C,a%20primary%20concern%2C%20KFF%20found
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=But%20these%20medications%20were%20originally,diabetes%2C%20weight%20loss%20treatment%20is